Skye is planning to initiate a Phase 2b clinical trial in obesity for nimacimab with ENHANZE in the middle of 2026. This study will also assess the combination of nimacimab and a GLP-1R agonist.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is one of the best affordable stocks with good earnings growth for 2026. Halozyme ...

Advanced diagnostics and AI-driven intelligence are no longer confined to automotive giants. They are reaching small garages, ...

Agreement supports development and commercialization of higher-dose, subcutaneous administration strategies for nimacimab SAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- Halozyme ...

They'll still have engines, but what kind? Here's what the world's largest auto supplier thinks about the future of American ...

The 1957 Corvette arrived looking familiar but hiding a revolution under its fiberglass skin. By pairing a small American ...

TubePilot AI secured $450,000 in private funding and incorporated in Delaware, scaling its ecosystem to 80+ specialized tools ...

Under the deal, ECARX will subscribe to 16,788,321 newly issued ordinary shares of Lotus Technology at a price of $1.37 per share, representing a total investment of $23 million.

He pleaded guilty in January 2025 to two counts related to not accounting for and paying employment taxes. Moore, who lived ...

The 1955 Mercedes-Benz 300SL did not just arrive in showrooms, it detonated into public consciousness as a road‑legal ...

First drive review of the new Tata Sierra 2025: spacious, tech-packed mid-size SUV with petrol & diesel options, premium ...

Bharat Electronics (BEL) rose 0.04%. The company said that it has received additional orders worth Rs 569 crore since December 12. These orders include radars, tank overhauls, communication equipment, ...